Jump to content

Pyridoxiphen

From Wikipedia, the free encyclopedia
(Redirected from Draft:Pyridoxiphen)
Pyridoxiphen
Clinical data
Other namesAmphetamine–pyridoxine condensation product; Phenamine–pyridoxine condensation product; Pyridoxyphen; Pyridoxiphene; Piridoksifen; Piridoksifena; Pyridoxylamphetamine
Identifiers
  • 4-(hydroxymethyl)-2-methyl-5-[(1-phenylpropan-2-ylamino)methyl]pyridin-3-ol
PubChem CID
ChemSpider
Chemical and physical data
FormulaC17H22N2O2
Molar mass286.375 g·mol−1
3D model (JSmol)
  • CC1=NC=C(C(=C1O)CO)CNC(C)CC2=CC=CC=C2
  • InChI=1S/C17H22N2O2/c1-12(8-14-6-4-3-5-7-14)18-9-15-10-19-13(2)17(21)16(15)11-20/h3-7,10,12,18,20-21H,8-9,11H2,1-2H3
  • Key:UDDSBCOQRRHWBZ-UHFFFAOYSA-N

Pyridoxiphen, also known as amphetamine–pyridoxine condensation product or as pyridoxylamphetamine, is a drug of the substituted amphetamine family which was developed in the Soviet Union in the 1960s.[1][2][3][4][5][6] It is the condensation product of amphetamine and pyridoxine (vitamin B6).[2] It was developed for potential treatment of central nervous system conditions.[2] The drug has sympatholytic and hypotensive effects in animals.[7][1][6][8] It is highly ionic and may not be able to cross the blood–brain barrier.[7]

See also

[edit]
  • Phenatine (N-nicotinoylamphetamine; amphetamine–niacin condensation product)

References

[edit]
  1. ^ a b Jablonski, S.; National Library of Medicine (U.S.) (1967). Russian Drug Index. Public Health Service publication. U.S. Department of Health, Education, and Welfare, Public Health Service. p. 245. Retrieved 4 October 2024. Pyridoxiphen (Piridoksifen). 4-Pyridinemethanol, 3-hydroxy-2-methyl-5-((α-methylphenethyl)amino)methyl)-, dihydrochloride. C17H22N2O2.2HCl. [Structure image.] Product of condensation of phenamine and pyridoxine. Arbuzov, S. Ia., & Smirnova, S. M. "Sympatholytic and hypotensive effects of pyridoxiphen" Farmakol Toksik, 1964, 27: No. 4, p. 420-3.
  2. ^ a b c Dange, S.A.; Adhikari, G.M. (1963). International Socialist Miscellany (in Italian). S.A. Dange and G. Adhikari. p. 131. Retrieved 4 October 2024. Our chair has also produced certain derivatives of phenatin which likewise possess valuable qualities. For instance, there is pyridoxiphen, a product of condensation of phenamin and pyridoxine (Vitamin B3). This preparation is necessary in clinical practice for treating some of the diseases of the nervous system. We are persistently looking for even more active stimulators. This calls for a still deeper knowledge of the processes of metabolism in the nervous tissues, processes that lead to the exhaustion of these tissues, This will provide man with a means of conquering fatigue for long.
  3. ^ Marler, E.E.J. (1983). Pharmacological and Chemical Synonyms: A Collection of Names of Drugs, Pesticides and Other Compounds Drawn from the Medical Literature of the World. Excerpta Medica. pp. 30, 419. ISBN 978-90-219-3061-9. Retrieved 4 October 2024. PYRIDOXIPHEN (tr) (amphetamine-pyridoxine condensation product)
  4. ^ Arbuzov SI, Aleksandrova AE, Amirnova SM (1966). "O vliianii piridoksifena na tsentral'nyiu nervnuiu sistemu" [On the action of pyridoxyphen on central nervous system]. Farmakol Toksikol (in Russian). 29 (5): 521–522. PMID 5995060.
  5. ^ Arbuzov SI, Gorodnik AG, Nikiforov MI (1968). "O vliianii piridoksifena na nekotorye funktsii nervnoĭ sistmey" [On the effect of pyridoxiphen on some functions of the nervous system]. Farmakol Toksikol (in Russian). 31 (2): 152–156. PMID 5674665.
  6. ^ a b Aerospace Technology Division, Library of Congress. "CBE Factors Monthly Survey No. 40, ATD Work Assignment No. 50 (ATD Report 69-77-50-10)" (PDF). Retrieved 4 October 2024. Compound I does not display the pronounced hypotensive action characteristic of Pirodoksifen (i.e., pyridoxylamphetamine) and Fenatin (i.e., nicotinoylamphetamine) nor the central stimulating effect of Fenatin.
  7. ^ a b Fitzpatrick, W.H. (1974). Soviet Research in Pharmacology and Toxicology, 1963-1972. DHEW publication no. (NIH) 75-696. National Institutes of Health. pp. 22, 77. Retrieved 4 October 2024. C. Other Drug Effects (32) investigated the action of Arbuzov, Aleksandrova et al. pyridoxyphen, a new adrenolytic, on the central nervous system. Pyridoxyphen, a product of the condensation of phenamine and pyridoxine, exerted no central adrenolytic action. Because of the highly ionic nature of the molecule, the authors concluded that pyridoxyphen was incapable of overcoming the hemato-encephalic barrier.
  8. ^ Arbuzov SI, Smirnova SM (1964). "Simpatoliticheskoe i gipotenzivnoe de istvie piridoksifena" [Sympatholytic and hypotensive effects of pyridoxiphen]. Farmakol Toksikol (in Russian). 27: 420–423. PMID 14193108.